Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice
Sihong Song(American Association of Colleges of Pharmacy), Terence R. Flotte(University of Massachusetts Chan Medical School), Kevin Goudy(University of Florida), Mark A. Atkinson(University of Florida), Marda Scott-Jorgensen(University of Florida), Clive Wasserfall(University of Florida), Martha Campbell‐Thompson(University of Florida), Jianan Wang(University of Florida), TM ELLIS(University of Florida), JM Crawford(University of Florida), Qiushi Tang(Chinese Journal of Integrated Traditional and Western Medicine)
Cited by 100
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k